ASEAN KEY DESTINATIONS
Indian trade deal to hit drug access
In a statement on Thursday, the Cambodian People Living with HIV/AIDS Network, or CPN, called on India to reject proposed intellectual property rules that it said could hamstring the country’s production of generic medicines.
“The EU is pushing for India to accept intellectual property provisions which would restrict India ’s production of generic medicines,” Keo Chen, the network’s national coordinator, said in the statement.
“India produces 90 percent of AIDS medicines used in Cambodia, so the health of people living with HIV is hanging in the balance.”
Echoing similar concerns from across the developing world, CPN stated that the EU’s push to include “patent term extensions” and other intellectual property provisions in the trade pact would reduce India’s ability to produce inexpensive generic drugs.
Other provisions sought by the EU, it stated, would oblige Delhi to prioritise the enforcement of intellectual property, or TRIPS, rules and “effectively deter” generic competition by Indian companies
Letters that do not contain full contact information cannot be published.
Letters become the property of AseanAffairs and may be republished in any format.
They typically run 150 words or less and may be edited
submit your comment in the box below